Vivold Consulting

SpaceX, Anthropic, and OpenAI listings will out-value every US VC-backed exit since 2000 - reshaping vendor economics for everyone

Key Insights

The new NVCA-Pitchbook Venture Monitor dropped a stunning claim: the pending OpenAI and Anthropic IPOs, together with SpaceX's listing, will generate more value than every US VC-backed exit since 2000 combined. SpaceX is already public at $1.77 trillion, and with both AI labs pushing toward trillion-dollar debuts, the trio should land north of $4 trillion - against roughly $70 billion in total US IPO proceeds last year. For anyone buying AI services, the labs' shift to public-market scrutiny will reshape pricing, transparency, and vendor stability.

Stay Updated

Get the latest insights delivered to your inbox

A quarter-century of exits, eclipsed in one season

It is easy to get numb to big AI numbers, but the Q2 NVCA-Pitchbook Venture Monitor report put this summer's IPO wave in a frame that cuts through: alongside the SpaceX listing, the pending OpenAI and Anthropic offerings will generate more value than all US VC-backed exits since 2000. Run the arithmetic and it holds up. SpaceX has already gone public at a $1.77 trillion valuation, and with both AI labs pushing into the trillions, the trio together should land somewhere north of $4 trillion. For scale, the SEC counted only about $70 billion in total US IPO proceeds last year, and Uber's $84 billion IPO - which felt enormous in 2019 - amounts to less than five percent of what SpaceX just raised.

The fine print, and why it still stands

The claim carries caveats worth knowing before you repeat it in a boardroom. It measures value created rather than liquid cash, excludes non-US listings like Alibaba, and misses value built inside already-public companies - the iPhone, Android, YouTube, and Instagram all happened post-IPO. But the comparison period was hardly quiet: it includes the IPOs of Google (2004), Tesla (2010), and Meta (2012), plus the $20-billion-plus acquisitions of LinkedIn, Slack, and WhatsApp. Even against that field, the current wave is unprecedented. Two structural forces explain it: companies now stay private far longer, so more appreciation happens pre-listing, and AI training is so capital-intensive that labs have been pushed into relentless mega-raises that inflate valuations before Wall Street ever gets a look. The filings back the timeline: Anthropic confidentially filed on June 1, weeks after a $65 billion round valued it at $965 billion, and OpenAI followed with its own confidential filing on June 8, reportedly targeting up to $1 trillion - even while telling investors it does not expect profitability until 2030 despite roughly $2 billion in monthly revenue as of March.

What this means if you buy, build, or invest

- If you procure AI services, public listings are quietly good news: quarterly reporting will expose the labs' real unit economics, capacity constraints, and margin pressure for the first time, giving you far better information for contract negotiations than today's leak-driven guesswork.
- Expect pricing turbulence in both directions. Public-market profitability pressure can push list prices up, but it also rewards volume commitments - lock multi-year rates where you have leverage, and keep a second provider warm.
- If you build on these platforms, the capital concentration is a dependency signal: the same handful of firms now anchoring the entire IPO market also anchor your stack. Pair every primary-model integration with a tested fallback, a lesson this year's export-control saga already taught the hard way.
- The report's own warning deserves attention: offerings at this scale are pushing financial infrastructure to its limit. If the listings wobble, expect a chill that reaches AI budgets, valuations, and hiring far beyond the three companies themselves - worth a line in any 2027 scenario plan you are drafting for clients.

Related Articles

An AWS knowledge-graph deployment turned 6-month research cycles into 3 weeks - and the blueprint transfers far beyond pharma

An AWS GraphRAG deployment in pharmaceutical research cut R&D cycles by 87% - initial discovery that took six months now closes in three weeks - by fusing siloed internal databases and public literature into one queryable knowledge graph on Amazon Neptune Analytics and Bedrock (running Claude). Every answer comes with verifiable citations and a mapped reasoning path, which is exactly what regulated industries need for compliance. The architecture is modular and, crucially, transferable: any enterprise drowning in fragmented legacy data can copy this pattern.

A 14-person open-source team just became the default way 8.9M developers run local AI - and a lever for slashing inference bills

Ollama, the open-source tool that lets developers run open-weight AI models on their own machines in minutes, raised a $65M Series B led by Theory Ventures ($88M total), revealing it now serves 8.9 million developers monthly and sits inside 85% of the Fortune 500 - with just 14 employees. Founders Jeff Morgan and Michael Chiang previously built Docker Desktop, and they're repeating the play: abstract away the hardware pain, then monetise a cloud tier priced on GPU time rather than tokens. The backdrop is the industry's loudest cost debate: every company with heavy inference bills is under existential pressure to shift routine workloads to open models.

Takeda pays ~$60M upfront with up to $600M tied to milestones - the outcome-based AI contract template every industry will copy

Japanese pharma giant Takeda signed a strategic collaboration with Insilico Medicine worth up to US$600 million, gaining exclusive worldwide rights to drug candidates surfaced by Insilico's Pharma.AI platform - but only about $60 million is upfront and near-term, with the rest gated behind preclinical, clinical, commercial, and sales milestones plus tiered royalties. It caps a staggering run for Insilico: over US$7 billion in combined deal value signed this year alone (Lilly, SK Biopharmaceuticals, now Takeda), and its Hong Kong shares jumped 13.5% on the news. The deal structure, not the headline number, is the real lesson for anyone buying or selling AI capability.